Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,307 | 21 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alcon Vision LLC | $352.32 | 4 | $0 (2024) |
| Amgen Inc. | $276.83 | 3 | $0 (2024) |
| ViiV Healthcare Company | $185.22 | 8 | $0 (2024) |
| Ocular Therapeutix, Inc. | $135.98 | 1 | $0 (2021) |
| Genentech USA, Inc. | $119.89 | 1 | $0 (2022) |
| Horizon Therapeutics plc | $109.82 | 2 | $0 (2022) |
| AcelRx Pharmaceuticals, Inc. | $103.92 | 1 | $0 (2021) |
| Johnson & Johnson Surgical Vision, Inc. | $23.25 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $656.90 | 8 | Alcon Vision LLC ($336.10) |
| 2023 | $154.07 | 7 | ViiV Healthcare Company ($137.85) |
| 2022 | $196.27 | 3 | Genentech USA, Inc. ($119.89) |
| 2021 | $239.90 | 2 | Ocular Therapeutix, Inc. ($135.98) |
| 2020 | $60.09 | 1 | Horizon Therapeutics plc ($60.09) |
All Payment Transactions
21 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/17/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $110.02 | General |
| Category: Inflammation/Rare Disease | ||||||
| 08/28/2024 | Johnson & Johnson Surgical Vision, Inc. | Tecnis Simplicity (Device) | Food and Beverage | In-kind items and services | $23.25 | General |
| Category: Optics | ||||||
| 08/23/2024 | Alcon Vision LLC | Clareon (Device) | Food and Beverage | In-kind items and services | $139.20 | General |
| Category: Ophthalmology | ||||||
| 07/24/2024 | Alcon Vision LLC | Clareon (Device) | Food and Beverage | In-kind items and services | $148.28 | General |
| Category: Ophthalmology | ||||||
| 07/22/2024 | Alcon Vision LLC | Centurion (Device) | Food and Beverage | In-kind items and services | $48.62 | General |
| Category: Ophthalmology | ||||||
| 03/04/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $74.61 | General |
| Category: Inflammation/Rare Disease | ||||||
| 03/03/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $92.20 | General |
| Category: Inflammation/Rare Disease | ||||||
| 02/06/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $20.72 | General |
| Category: HIV | ||||||
| 12/13/2023 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $28.88 | General |
| Category: HIV | ||||||
| 11/30/2023 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $23.85 | General |
| Category: HIV | ||||||
| 11/13/2023 | Alcon Vision LLC | Clareon (Device) | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: Ophthalmology | ||||||
| 07/06/2023 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $26.52 | General |
| Category: HIV | ||||||
| 06/29/2023 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $1.54 | General |
| Category: HIV | ||||||
| 06/28/2023 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $31.76 | General |
| Category: HIV | ||||||
| 05/03/2023 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $25.30 | General |
| Category: HIV | ||||||
| 11/10/2022 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $26.65 | General |
| Category: HIV | ||||||
| 09/29/2022 | Genentech USA, Inc. | VABYSMO (Drug) | Food and Beverage | In-kind items and services | $119.89 | General |
| Category: Immunology and Ophthalmology | ||||||
| 02/14/2022 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $49.73 | General |
| Category: TEPEZZA | ||||||
| 11/29/2021 | AcelRx Pharmaceuticals, Inc. | DSUVIA (Drug) | Food and Beverage | In-kind items and services | $103.92 | General |
| Category: PAIN MANAGEMENT | ||||||
| 11/11/2021 | Ocular Therapeutix, Inc. | DEXTENZA (Drug) | Food and Beverage | In-kind items and services | $135.98 | General |
| Category: Corticosteroid intracanalicular insert | ||||||
| 03/11/2020 | Horizon Therapeutics plc | — | Food and Beverage | In-kind items and services | $60.09 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 349 | 488 | $110,261 | $21,900 |
| 2022 | 9 | 278 | 382 | $90,378 | $17,798 |
| 2021 | 8 | 238 | 728 | $105,099 | $19,890 |
| 2020 | 5 | 136 | 180 | $59,928 | $12,187 |
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92014 | Established patient complete exam of visual system | Office | 2023 | 106 | 133 | $51,471 | $12,110 | 23.5% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 72 | 110 | $42,957 | $7,931 | 18.5% |
| 92134 | Imaging of retina | Office | 2023 | 28 | 33 | $7,038 | $998.51 | 14.2% |
| 92133 | Imaging of optic nerve | Office | 2023 | 20 | 21 | $4,347 | $601.80 | 13.8% |
| J2280 | Injection, moxifloxacin, 100 mg | Office | 2023 | 23 | 28 | $476.00 | $174.35 | 36.6% |
| J7120 | Ringers lactate infusion, up to 1000 cc | Office | 2023 | 29 | 35 | $665.00 | $54.52 | 8.2% |
| J3010 | Injection, fentanyl citrate, 0.1 mg | Office | 2023 | 27 | 35 | $1,144 | $21.51 | 1.9% |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | Office | 2023 | 29 | 76 | $1,348 | $7.55 | 0.6% |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | Office | 2023 | 15 | 17 | $815.00 | $1.15 | 0.1% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 88 | 107 | $41,409 | $9,567 | 23.1% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 55 | 85 | $32,895 | $5,569 | 16.9% |
| 00142 | Anesthesia for lens surgery | Office | 2022 | 11 | 13 | $7,084 | $1,470 | 20.8% |
| 92134 | Imaging of retina | Office | 2022 | 15 | 15 | $3,105 | $542.81 | 17.5% |
| 92133 | Imaging of optic nerve | Office | 2022 | 14 | 15 | $3,105 | $461.07 | 14.8% |
| J2280 | Injection, moxifloxacin, 100 mg | Office | 2022 | 15 | 15 | $255.00 | $106.67 | 41.8% |
| J7120 | Ringers lactate infusion, up to 1000 cc | Office | 2022 | 24 | 30 | $580.00 | $54.94 | 9.5% |
| J3010 | Injection, fentanyl citrate, 0.1 mg | Office | 2022 | 27 | 33 | $744.00 | $18.87 | 2.5% |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | Office | 2022 | 29 | 69 | $1,201 | $7.62 | 0.6% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 82 | 112 | $43,344 | $10,227 | 23.6% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2021 | 55 | 95 | $36,765 | $6,801 | 18.5% |
| 00142 | Anesthesia for lens surgery | Office | 2021 | 12 | 19 | $11,132 | $2,074 | 18.6% |
| 92083 | Measurement of field of vision during daylight conditions, extended examination | Office | 2021 | 14 | 15 | $4,650 | $711.11 | 15.3% |
| J7120 | Ringers lactate infusion, up to 1000 cc | Office | 2021 | 17 | 27 | $671.00 | $51.40 | 7.7% |
| J3010 | Injection, fentanyl citrate, 0.1 mg | Office | 2021 | 19 | 26 | $991.00 | $11.54 | 1.2% |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | Office | 2021 | 14 | 360 | $6,120 | $7.04 | 0.1% |
About Dr. Barbara Yates, MD
Dr. Barbara Yates, MD is a Ophthalmology healthcare provider based in Burbank, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/28/2007. The National Provider Identifier (NPI) number assigned to this provider is 1164616686.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Barbara Yates, MD has received a total of $1,307 in payments from pharmaceutical and medical device companies, with $656.90 received in 2024. These payments were reported across 21 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($1,307).
As a Medicare-enrolled provider, Yates has provided services to 1,001 Medicare beneficiaries, totaling 1,778 services with total Medicare billing of $71,775. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.
Practice Information
- Specialty Ophthalmology
- Location Burbank, CA
- Active Since 08/28/2007
- Last Updated 07/01/2014
- Taxonomy Code 207W00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1164616686
Products in Payments
- Clareon (Device) $303.70
- DOVATO (Drug) $185.22
- UPLIZNA (Biological) $166.81
- DEXTENZA (Drug) $135.98
- VABYSMO (Drug) $119.89
- TEPEZZA (Biological) $110.02
- DSUVIA (Drug) $103.92
- TEPEZZA (Drug) $49.73
- Centurion (Device) $48.62
- Tecnis Simplicity (Device) $23.25
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Burbank
Dr. Alan Berg, M.d, M.D
Ophthalmology — Payments: $43,560
Dr. Robert Feinfield, M.d, M.D
Ophthalmology — Payments: $22,187
Dr. Lynn Huang, Md, Mph, MD, MPH
Ophthalmology — Payments: $4,998
Armin Vishteh, Md, MD
Ophthalmology — Payments: $4,450
Dr. Suhas Tuli, M.d, M.D
Ophthalmology — Payments: $3,932
Dr. Bonnie Sklar, Md, MD
Ophthalmology — Payments: $3,070